|
業務類別
|
Biotechnology |
|
業務概覽
|
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH. |
| 公司地址
| 101 Redwood Shores Parkway, Redwood City, CA, USA, 94065 |
| 電話號碼
| +1 650 327-3270 |
| 傳真號碼
| +1 650 327-3218 |
| 公司網頁
| https://www.corcept.com |
| 員工數量
| 730 |
| Dr. Joseph K. Belanoff, M.D. |
Director, President and Chief Executive Officer |
美元 1.18M |
17/04/2026 |
| Mr. G. Charles Robb |
Chief Business Officer and Secretary |
美元 711.41K |
17/04/2026 |
| Mr. Atabak Mokari |
Chief Financial Officer and Treasurer |
美元 566.35K |
17/04/2026 |
| Mr. Sean Maduck |
President, Corcept Endocrinology |
美元 648.86K |
17/04/2026 |
| Mr. Joseph Douglas Lyon |
Chief Accounting Officer and Chief Technology Officer |
-- |
17/04/2026 |
| Dr. Hazel Hunt, PhD |
Chief Scientific Officer |
-- |
17/04/2026 |
| Dr. William Guyer, Pharm.D. |
Chief Development Officer |
美元 706.39K |
17/04/2026 |
|
|
| Mr. David L. Mahoney |
Independent Director |
17/04/2026 |
| Mr. Daniel N. Swisher,Jr |
Independent Director |
17/04/2026 |
| Mr. George Leonard Baker, Jr |
Independent Director |
17/04/2026 |
| Dr. Gregg H. Alton, J.D. |
Independent Director |
17/04/2026 |
| Dr. Joseph K. Belanoff, M.D. |
Director, President and Chief Executive Officer |
17/04/2026 |
| Mr. James N. Wilson |
Chairman of the Board |
17/04/2026 |
| Ms. Kimberly Park |
Independent Director |
17/04/2026 |
| Mr. Joshua M. Murray |
Independent Director |
17/04/2026 |
|
|
|
|
